SHANGHAI, Aug. 31 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing Service Company in China, announced today that it received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26. The award was announced at the 10th anniversary celebration of "Focus on Zhangjiang Festival" in August. Dr. Tong Xu, Sundia's Vice President for Process Chemistry and GMP Operations, attended the ceremony. "Zhangjiang Hi-Tech Park is China's most successful high technology park which many top high tech start-up companies in China have chosen as their home. I am honored to be here today to receive this award for Sundia," said Dr. Xu.
In August of 1999, Shanghai Municipal Government declared a "Focus on Zhangjiang" strategy to utilize all resources of the city with support from the central Chinese government to make Zhangjiang Park the technology innovation highland of the country. Ten years later, Zhangjiang has become the national biotech & pharmaceutical industry base, which has attracted more than 300 biotech and pharmaceutical companies from all over the world. Sundia Meditech Company, founded in 2004 in Zhangjiang, has kept a high speed for business growth in the past 5 years. For the year 2008, Sundia ranked #52 in Deloitte technology Fast 500 Asia Pacific list, and #16 in Fast 50 China list, with its 928% revenue growth. It was named one of the 50 best companies for investment in 2007 and 2008.
"We are lucky that we made the decision to come to Zhangjiang to start Sundia 5 years ago," said Dr. Wang Xiaochuan, Sundia's Chairman and CEO. "Zhangjiang Hi-Tech Park announced a New Drug Incubation Platform earlier this year to combine venture capitals, intellectual properties, and CRO resources together to support new drug discovery and development programs in the park. Sundia was selected by Zhangjiang as the leading CRO provider to this platform based on our outstanding track record in CRO services. We will try our best to support Zhangjiang Hi-Tech Park to make this platform a success."
About Sundia MediTech
Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.
|SOURCE Sundia MediTech Company|
Copyright©2009 PR Newswire.
All rights reserved